Ticker	Volume	Price	Price Delta
DJIA	15,179.80	+109.67	0.73%
S&P 500	1,639.04	+12.31	0.76%
Nasdaq	3,452.13	+28.58	0.83%

Ticker

Volume

Price

Price Delta

DJIA

15,179.80

+109.67

0.73%

S&P 500

1,639.04

+12.31

0.76%

Nasdaq

3,452.13

+28.58

0.83%

Ticker	Volume	Price	Price Delta
STOXX 50	2,702.69	+35.37	1.33%
FTSE 100	6,330.49	+22.23	0.35%
DAX	8,215.73	+87.77	1.08%

Ticker

Volume

Price

Price Delta

STOXX 50

2,702.69

+35.37

1.33%

FTSE 100

6,330.49

+22.23

0.35%

DAX

8,215.73

+87.77

1.08%

Ticker	Volume	Price	Price Delta
Nikkei	12,941.80	-91.32	-0.70%
Hang Seng	21,088.90	-136.99	-0.65%
S&P/ASX 200	4,783.00	-42.88	-0.89%

Ticker

Volume

Price

Price Delta

Nikkei

12,941.80

-91.32

-0.70%

Hang Seng

21,088.90

-136.99

-0.65%

S&P/ASX 200

4,783.00

-42.88

-0.89%

Exchange: ASE
Sector: Health Care
Industry: Medical Equipment/Devices
Sub-Industry: Cardiovascular Devices

Optiscan Imaging Ltd

+ Add to Watchlist

OIL:AU

0.0770 AUD 0.0010 1.32%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 23:18:37 ET on 06/17/2013.

Snapshot for Optiscan Imaging Ltd (OIL)

Open:	0.0770	Day's Range:	0.0770 - 0.0770	Volume:	3,090
Previous Close:	0.0760	52wk Range:	0.0650 - 0.1400	1-Yr Rtn:	-8.33%

Stock Chart for OIL

No chart data available.

OIL:AU 0.0770

0.0760

Interactive OIL Chart

…

Previous Close

Key Statistics for OIL

Current P/E Ratio (ttm)	-
Estimated P/E(-)	-
Relative P/E vs. AS51	-
Earnings Per Share (ttm)	-0.0117
Est. EPS	-
Est. PEG Ratio	-
Market Cap (M AUD)	12.48
Shares Outstanding (M)	162.09
30 Day Average Volume	44,547
Price/Book (mrq)	7.5867
Price/Sale (ttm)	11.0636
Dividend Indicated Gross Yield	-%
Cash Dividend	-
Last Dividend
5 Year Dividend Growth	-
Next Earnings Announcement	09/13/2013

mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OIL

Revenue
Net Income (M/AUD)

Profit Margin (%)

Company Profile & Key Executives for OIL

Optiscan Imaging Limited is a proprietor of patents which enable a confocal microscope to be miniaturized to the point where a confocal endomicroscope is made possible. The process enables living tissue to be examined non-invasively at a cellular level, opening up the possibilities for non-invasive disease monitoring and diagnosis.